We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
926
STAAR Surgical
STAA
$1.21B
$187K 0.01%
10,000
+1,020
+11% +$19.5K
SLQT icon
927
SelectQuote
SLQT
$132M
$187K 0.01%
296,954
+62,610
+27% +$65.8K
ADUR
928
Aduro Clean Technologies
ADUR
$488M
$187K 0.01%
+17,782
New +$210K
JMIA
929
Jumia Technologies
JMIA
$737M
$186K 0.01%
27,000
-500
-2% -$5.04K
MIR icon
930
Mirion Technologies
MIR
$3.73B
$186K 0.01%
10,000
-1,085
-10% -$24.5K
CORN icon
931
Teucrium Corn Fund
CORN
$176M
$184K 0.01%
+10,000
New +$178K
MAGN
932
Magnera Corp
MAGN
$472M
$184K 0.01%
19,299
+3,760
+24% +$48.1K
HLX icon
933
Helix Energy Solutions
HLX
$1.4B
$183K 0.01%
18,500
-34,000
-65% -$289K
FENC icon
934
Fennec Pharmaceuticals
FENC
$332M
$182K 0.01%
+29,599
New +$229K
SAIL
935
SailPoint Inc
SAIL
$9.51B
$182K 0.01%
13,719
AVTR icon
936
Avantor
AVTR
$9.32B
$180K 0.01%
23,000
+6,000
+35% +$59K
AUR icon
937
Aurora
AUR
$12.6B
$179K 0.01%
43,347
-38,486
-47% -$170K
FSP
938
Franklin Street Properties
FSP
$47.2M
$179K 0.01%
268,759
+65,000
+32% +$50.3K
NXE icon
939
NexGen Energy
NXE
$6.06B
$177K 0.01%
15,268
-28,973
-65% -$346K
AMRX icon
940
Amneal Pharmaceuticals
AMRX
$5.85B
$177K 0.01%
+14,210
New +$191K
ARDT
941
Ardent Health
ARDT
$1.53B
$177K 0.01%
20,620
-14,039
-41% -$126K
BMM
942
Blue Moon Metals Inc
BMM
$541M
$176K 0.01%
+27,127
New +$132K
DXC icon
943
DXC Technology
DXC
$1.82B
$176K 0.01%
+14,000
New +$188K
HBAN icon
944
Huntington Bancshares
HBAN
$34.4B
$176K 0.01%
+11,240
New +$192K
CXM icon
945
Sprinklr
CXM
$1.49B
$175K 0.01%
29,200
+8,384
+40% +$52K
INTR icon
946
Inter&Co
INTR
$2.47B
$175K 0.01%
+22,000
New +$191K
BLMN icon
947
Bloomin' Brands
BLMN
$741M
$175K 0.01%
32,389
-3,687
-10% -$23.6K
FRSH icon
948
Freshworks
FRSH
$3.14B
$173K 0.01%
21,524
-29,887
-58% -$276K
BKD icon
949
Brookdale Senior Living
BKD
$3.49B
$172K 0.01%
+12,602
New +$177K
LAC
950
Lithium Americas
LAC
$1.01B
$171K 0.01%
43,318
+23,872
+123% +$117K

Similar funds

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.